Anti-APOC4/ APO-CIV/ APOC-IV functional antibody
Anti-APOC4/ APO-CIV/ APOC-IV functional antibody for cell culture, ELISA & in-vivo assay
Go to APOC4/APOC4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0674-Ab-1/ GM-Tg-hg-SE0674-Ab-2 | Anti-Human APOC4 monoclonal antibody | Human |
GM-Tg-rg-SE0674-Ab-1/ GM-Tg-rg-SE0674-Ab-2 | Anti-Rat APOC4 monoclonal antibody | Rat |
GM-Tg-mg-SE0674-Ab-1/ GM-Tg-mg-SE0674-Ab-2 | Anti-Mouse APOC4 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0674-Ab-1/ GM-Tg-cynog-SE0674-Ab-2 | Anti-Cynomolgus/ Rhesus macaque APOC4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0674-Ab-1/ GM-Tg-felg-SE0674-Ab-2 | Anti-Feline APOC4 monoclonal antibody | Feline |
GM-Tg-cang-SE0674-Ab-1/ GM-Tg-cang-SE0674-Ab-2 | Anti-Canine APOC4 monoclonal antibody | Canine |
GM-Tg-bovg-SE0674-Ab-1/ GM-Tg-bovg-SE0674-Ab-2 | Anti-Bovine APOC4 monoclonal antibody | Bovine |
GM-Tg-equg-SE0674-Ab-1/ GM-Tg-equg-SE0674-Ab-2 | Anti-Equine APOC4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0674-Ab-1/ GM-Tg-hg-SE0674-Ab-2; GM-Tg-rg-SE0674-Ab-1/ GM-Tg-rg-SE0674-Ab-2; GM-Tg-mg-SE0674-Ab-1/ GM-Tg-mg-SE0674-Ab-2; GM-Tg-cynog-SE0674-Ab-1/ GM-Tg-cynog-SE0674-Ab-2; GM-Tg-felg-SE0674-Ab-1/ GM-Tg-felg-SE0674-Ab-2; GM-Tg-cang-SE0674-Ab-1/ GM-Tg-cang-SE0674-Ab-2; GM-Tg-bovg-SE0674-Ab-1/ GM-Tg-bovg-SE0674-Ab-2; GM-Tg-equg-SE0674-Ab-1/ GM-Tg-equg-SE0674-Ab-2 |
Products Name | Anti-APOC4 monoclonal antibody |
Format | mab |
Target Name | APOC4 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-APOC4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0674-Ag-1 | Recombinant multi-species APOC4/ APO-CIV/ APOC-IV protein |
Target information
Target ID | GM-SE0674 |
Target Name | APOC4 |
Gene ID | 346,11425,680551,718319,111097895,101086270,618041,100065506 |
Gene Symbol and Synonyms | Acl,APO-CIV,APOC-IV,APOC4 |
Uniprot Accession | P55056,P55797,Q3SYR5 |
Uniprot Entry Name | APOC4_HUMAN,APOC4_RAT,APOC4_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Ovary Cancer, IgA glomerulonephritis |
Gene Ensembl | ENSG00000267467 |
Target Classification | N/A |
The target: APOC4, gene name: APOC4, also named as APO-CIV, APOC-IV. This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is thought to play a role in lipid metabolism. Polymorphisms in this gene may influence circulating lipid levels and may be associated with coronary artery disease risk. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring downstream apolipoprotein C-II (APOC2) gene. [provided by RefSeq, Mar 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.